An Extension Study of Safety and Tolerability of SEP-363856 in Adult Subjects With Schizophrenia
Public ClinicalTrials.gov record NCT02970929. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 26-Week Open-label Safety and Tolerability Extension Study of SEP-363856 in Adult Subjects With Schizophrenia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
An extension study of safety and tolerability of SEP-363856 in adult subjects with schizophrenia
Study identification
- NCT ID
- NCT02970929
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 157 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 40 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2017 (Actual)
- Primary completion
- Jan 29, 2019 (Actual)
- Completion
- Jan 29, 2019 (Actual)
- Last update posted
- Jul 5, 2024
2017 – 2019
United States locations
- U.S. sites
- 6
- U.S. states
- 5
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Woodland International research Group | Little Rock | Arkansas | 72211 | — |
| CNRI-Los Angeles, LLC | Pico Rivera | California | 90660 | — |
| UCSD Medical Center UCSD Department of Psychiatry | San Diego | California | 92103-8229 | — |
| Atlanta Center for Medical Research | Atlanta | Georgia | 30331 | — |
| Kashinath Yadalam | Lake Charles | Louisiana | 70629 | — |
| Pillar Clinical Research, LLC | Dallas | Texas | 75243 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 24 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02970929, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 5, 2024 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02970929 live on ClinicalTrials.gov.